hotspot -WSS

hotspot

author：fashion 2025-10-03 00:07:52 - browse：1

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Pregnant women don't need prenatal multivitamins, study concludes

WSS

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Radiation, mainstay of cancer treatment, begins a fade

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Study finds new variant for Parkinson’s in African populations

FDA panel gives mixed vote on blood pressure devices

As pharma fights Medicare drug negotiation, hospitals, docs silent

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Supreme Court strikes down use of affirmative action

Immune cells and nerve overgrowth may explain recurring UTI pain

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

For AI in health care standards, federal regulators join with industry group

Supreme Court strikes down use of affirmative action

Medicare drug price negotiation hearing pits pharma v Biden admin

Duchenne breakthrough therapy leaves behind pioneering families

As pharma fights Medicare drug negotiation, hospitals, docs silent

State Dept. review finds Biden bears some blame for Afghanistan failures

What do new weight loss drugs mean for bariatric surgery?

hotspot

Study finds new variant for Parkinson’s in African populations

Immune cells and nerve overgrowth may explain recurring UTI pain

Ozempic has benefits for kidney disease as well as diabetes

Harvard's David Sinclair gets blowback over aging

Australia’s approach to dialysis celebrates life

Streamlined flu vaccines recommended by FDA advisory panel

entertainment

hotspot

Wikipedia

explore